estimate pt hold
trim ep gm fx pt post cl mix
encourag progress em incl china acceler hill focu
premium improv org sale trend though gm improv long
key enabl investment/profit growth cl remain elus restor credibl
key co regain foot price-to-earnings valuat look fair in-
result mix familiar headwind weigh margin cl report in-lin
org sale growth vs street howev margin expect
compani cite familiar headwind sale mix higher input cost wors fx
put take gm miss sg beat along help lower tax
rate deliv ep vs street consist gm shortfal remain
concern cl expect gm improv yoy doubl premium
mix product effort
ep guidanc re-affirmed w/organ sale edg higher gm lower cl
reiter ep guid impli vs street w/ strong top-line
trend off-set stepped-up invest support innov wors expect
fx org sale guid rais vs high-end previously/street
cl expect slight declin gm vs expans owe unfavor
product/geograph mix fx raw materi key enabl margin expansion/
reinvest gm expans visibl becom challeng cl
recent year cl tax rate expect vs reflect
reduct corp tax india
takeaway confer call skin pleas acquir skin
care brand filorga pca eltamd underscor growth/gm mix benefit ii
em trend china ahead expect greater china region deliv org
sale growth brazil slight slowdown consum continu pretti
colgat total market share global despit bp yoy declin us share brazil
diet re-launch us help drive strong org sale growth qtr gm
post recent disappoint laser focus product premium ahead
guid vi competit env gener ration save brazil odd price
adjust estim maintain hold trim ep gm fx post cl
mix qtr reiter ep guidanc sequenti improv org sale
em encourag co premium strategi appropri howev
protract gm issu concern valuat look fair ntm price-to-earnings in-
line yr average vs hpc peer updat pt impli share trade
price-to-earnings close current multipl hpc peer average reiter hold rate w/better
opportun group top pick chd/enr hpc
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
organ sale growth
oper margin declin bp
bp expans
ep lower due step invest
normal
price target ev/ebitda
ntm ebitda ev/ulfcf
bp top-line volum upsid rebound
bp oper margin upsid increment
product potenti commod tailwind
price target ev/ebitda
ntm ebitda ev/ulfcf
bp top-line volum downsid emerg market
bp margin pressur increas trade
promot unfavor move commod
price target ev/ebitda
ntm ebitda ev/ulfcf
colgat view potenti target larg
colgat oral care franchis among best
busi cpg market share growth
cl lever among coverag recoveri
emerg market
pleas see import disclosur inform page report
vs street gm vs
off-set lower sg drive modest
oi downsid ep beat street
though lift tax
net sale growth flat low-single-digit reiter
gross margin declin slightli vs gm expans prior
advertis expect around ytd rate reiter
tax rate previous
guidanc point
gross margin expect yoy
advertis expect around ytd rate
cl increas org sale guid m/p
vs prior in-lin w/street lower gm
guid though maintain outlook
pleas see import disclosur inform page report
actualjef estimate million except incom expens incom compositionreport org sale bpsfx bp sale bpsmargin analysisgross bpsoper bpsebitda bpstax bp equiti research
colgat thesi chart
chart despit recent improv near-term macro
competit pressur em like keep cl org sale
growth well histor averag
chart compani face materi moder vs best-
in-class growth
chart expect cl oi growth remain pressur
near-to-intermedi term well growth
chart colgat histor margin enhanc
impress howev recent gm pressur higher
invest weigh margin
chart despit higher margin/fcf profil vs stapl cl
increasingli uncertain outlook weigh stock
multipl view
chart cl valuat emb littl strateg halo busi
stall news report potenti suitor last report
quiet front
pleas see import disclosur inform page report
develop market growth market growth organ sale growth em/dm em/dm org sale growth em org sale growthdm org sale growthtot sale growth fx neutral oi growth org sale growthfx neutral oi margin ebitda margin ebitda right axi gm left org salesgrowthebitda conversionul p/ecl vs peer metric clstapl peer ntm ev/ebitda vs peer nielsen result period end
chart cl four-week quarterli sale growth
nielsen xaoc jefferi note nielsen definit may differ compani defin
pleas see import disclosur inform page report
quarterli sale growth sale growth yoy sale growthtwo-year averag sale growthxaoc ccolgat palmol mixlatest soap-light cleaners-multi sale chg vs yageq sale chg vs yagavg eq price chg vs yagdollar share pt chg vs yageq share pt chg vs yag sold promo pt chg vs yag us market share dashboard
chart colgat sale growth vs industri growth left portfolio gain market share right
pleas see import disclosur inform page report
us track channel growth vs industryweight industri growthcl sale portfolio gain valu sharetrail averagetrail ltm averag colgat valuat look fair rel consum
pleas see import disclosur inform page report
pleas see import disclosur inform page report
colgat trade near recent averag vs hpc
chart cl histor ntm price-to-earnings multipl vs
pleas see import disclosur inform page report
summar price target forecast upsid downsid scenario cl
stock base ntm estim util ev/ebitda ev/ulfcf
valuat framework flex upsid downsid scenario rel forecast
ebitda ulfcf net see modest upsid stock
next twelv month tsr upsid scenario call tsr downsid
chart upsid target downsid scenario
pleas see import disclosur inform page report
base ntm estimatesjefblendedtsrimpliedscenariosebitdamultiplepriceulfcfmultiplepricestock scenariosgrowth rebound margin upsid share trade premiumresult remain mute invest year valuat premium returnsgrowth slow margin downsid reinvest valuat discountdownside- volum downsid continu em deceler market share loss- bp margin pressur increas trade promot commodities- valuat blend ev/ebitda ev/ulfcf impli price-to-earnings ev/ebitda volum upsid increment margin rebound em growth- bp margin improv increment product commod tailwinds- valuat blend ev/ebitda ev/ulfcf impli price-to-earnings organ sale growth om declin invest spend expand bp valuat blend ev/ebitda ev/ulfcf impli price-to-earnings ev/ulfcf valu driver equiti research
organ sale growth segment
pleas see import disclosur inform page report
colgat organ sale growth total cltwo-year market organ sale growth emerg marketstwo-year market organ sale growth develop marketstwo-year organ sale growth oral two-year america organ sale growth north americatwo-year america organ sale growth latin americatwo-year averag chart europ organ sale growth
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
